37 citations
,
May 1999 in “Australasian Journal of Dermatology”
This review discusses neutrophil-associated and infiltrative scarring alopecias, as well as promising new treatments, but reports no new clinical results.
19 citations
,
January 2016 in “Dermatology Research and Practice”
This study observed that telogen effluvium was the most common form of acquiredalopecia among females in a semiurban Indian population, with stress and chemical exposure as major exacerbating factors.
In this retrospective study conducted at a dermatology institute in Mexico, researchers analyzed 1,888 adult alopecia cases, identifying alopecia areata as the most common type. The study underscores the importance of regional studies to better understand alopecia patterns and inform management strategies.
44 citations
,
November 1998 in “Australasian Journal of Dermatology”
This review provides a framework for diagnosing acquired scalp alopecias and discusses both non-scarring and scarring types, but reports no new clinical results.
The user discusses their experience with diffuse unpatterned alopecia and acquired progressive hair kinkering, noting improvements with treatments including biotin, pantothenic acid, finasteride, ketoconazole, and zinc pyrithione shampoo. They report thicker, healthier hair and improved scalp condition, attributing success mainly to biotin, pantothenic acid, and finasteride.
Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.
A young man faces severe hair loss in his early 20s, using treatments like dutasteride and minoxidil with little success, impacting his self-esteem and relationships. He considers hair systems and therapy as potential solutions.
A user experienced significant hair regrowth after 24 months using 1mg daily Dutasteride and 2.5-5mg oral Minoxidil for diffuse unpatterned alopecia. The discussion covers treatment effectiveness, side effects, and comparisons with Finasteride.
Clascoterone is a topical treatment for androgenetic alopecia, showing modest to moderate hair regrowth, and may be available by 2027-2028. It is considered safer than finasteride, with discussions on its effectiveness compared to RU58841 and pyrilutamide.
Got small bald circles with no warning? Centella creams might calm the area and kickstart new growth.There is no published human trial of Centella asiatica for alopecia areata or any other hair loss; the only hair-related studies are cell-culture work. Community users describe Centella creams as soothing for an irritated scalp, not as regrowth treatments, and a new bald patch needs a doctor's diagnosis first.